New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
Abstract Background A validated prognostic index for the outcome of patients with advanced high-grade serous ovarian cancer (HGSOC) undergoing neoadjuvant chemotherapy (NACT) remains elusive. To address this need, we developed an ovarian neoadjuvant chemotherapy prognostic index (ONCPI) to improve p...
Váldodahkkit: | , , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
BMC
2024-12-01
|
Ráidu: | BMC Cancer |
Fáttát: | |
Liŋkkat: | https://doi.org/10.1186/s12885-024-13324-0 |